These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7987980)

  • 1. Cellular pharmacology of D-3-azido-3-deoxy-myo-inositol, an inhibitor of phosphatidylinositol signaling having antiproliferative activity.
    Brunn G; Fauq AH; Chow S; Kozikowski AP; Gallegos A; Powis G
    Cancer Chemother Pharmacol; 1994; 35(1):71-9. PubMed ID: 7987980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-3-deoxy-3-substituted myo-inositol analogues as inhibitors of cell growth.
    Powis G; Aksoy IA; Melder DC; Aksoy S; Eichinger H; Fauq AH; Kozikowski AP
    Cancer Chemother Pharmacol; 1991; 29(2):95-104. PubMed ID: 1760864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate properties of analogs of myo-inositol.
    Moyer JD; Reizes O; Ahir S; Jiang C; Malinowski N; Baker DC
    Mol Pharmacol; 1988 Jun; 33(6):683-9. PubMed ID: 2837638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 3-modified 1D-myo-inositols as inhibitors and substrates of phosphatidylinositol synthase and inhibitors of myo-inositol uptake by cells.
    Johnson SC; Dahl J; Shih TL; Schedler DJ; Anderson L; Benjamin TL; Baker DC
    J Med Chem; 1993 Nov; 36(23):3628-35. PubMed ID: 8246231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-hydroxyl of myo-inositol is essential for uptake into HSDM1C1 mouse fibrosarcoma cells.
    Auchus RJ; Wilson DB; Covey DF; Majerus PW
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1139-46. PubMed ID: 4026861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uptake of 3H-labelled monodeoxyfluoro-myo-inositols into thymocytes and their incorporation into phospholipid in permeabilized cells.
    Offer J; Metcalfe JC; Smith GA
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):553-60. PubMed ID: 8387272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphatidylinositol synthase of proximal tubule cells.
    Galvao C; Shayman JA
    Biochim Biophys Acta; 1990 May; 1044(1):34-42. PubMed ID: 2160284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast mutant defective in synthesis of phosphatidylinositol. Isolation and characterization of a CDPdiacylglycerol--inositol 3-phosphatidyltransferase Km mutant.
    Nikawa J; Yamashita S
    Eur J Biochem; 1982 Jul; 125(2):445-51. PubMed ID: 6288375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
    Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by Ca2+ of the incorporation of myo-inositol into phosphatidylinositol.
    Egawa K; Takenawa T; Sacktor B
    Mol Cell Endocrinol; 1981 Jan; 21(1):29-35. PubMed ID: 6259001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myo-inositol does not modulate PI turnover in MDCK cells under hyperosmolar conditions.
    Shayman JA; Wu D
    Am J Physiol; 1990 May; 258(5 Pt 2):F1282-7. PubMed ID: 2159718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol synthetase activities in neuronal nuclei and microsomal fractions isolated from immature rabbit cerebral cortex.
    Baker RR; Chang H
    Biochim Biophys Acta; 1990 Jan; 1042(1):55-61. PubMed ID: 2153412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of inositol analogues as inhibitors of the phosphoinositide pathway, and incorporation of 2-deoxy-2-fluoro-myo-inositol to give analogues of phosphatidylinositol intermediates.
    McPhee F; Downes CP; Lowe G
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):407-12. PubMed ID: 1650182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol:myo-inositol exchange activity in intact nerve endings: substrate and cofactor dependence, nucleotide specificity, and effect on synaptosomal handling of myo-inositol.
    Berry G; Yandrasitz JR; Cipriano VM; Hwang SM; Segal S
    J Neurochem; 1986 Apr; 46(4):1073-80. PubMed ID: 3005502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells.
    Nakamura J; Del Monte MA; Shewach D; Lattimer SA; Greene DA
    Am J Physiol; 1992 Apr; 262(4 Pt 1):E417-26. PubMed ID: 1314495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unimpaired formation of hormone-stimulated inositol trisphosphate in human mesangial cells under hyperglycemic conditions.
    Greenberg L; Urbanes AQ; Shayman JA
    Biochim Biophys Acta; 1992 Mar; 1138(3):229-35. PubMed ID: 1312360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for attenuation of myo-inositol uptake, phosphoinositide turnover and inositol phosphate production in aortic vasculature of rats during pregnancy.
    Conrad KP; Barrera SA; Friedman PA; Schmidt VM
    J Clin Invest; 1991 May; 87(5):1700-9. PubMed ID: 1850759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone (GnRH) rapidly stimulates the formation of inositol phosphates and diacyglycerol in rat granulosa cells: further evidence for the involvement of Ca2+ and protein kinase C in the action of GnRH.
    Davis JS; West LA; Farese RV
    Endocrinology; 1986 Jun; 118(6):2561-71. PubMed ID: 3009164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CDP-DG: inositol transferase by inostamycin.
    Imoto M; Taniguchi Y; Umezawa K
    J Biochem; 1992 Aug; 112(2):299-302. PubMed ID: 1328172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML; Soulage CO
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.